The Soaring Prevalence Of Chronic Diseases Fuels Expansion In The Cell Therapy Market Is Supporting Development Across The Cell Therapy Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Market Size Is Forecasted For The Cell Therapy Market By 2030 Based On Its 2026 Value?

The cell therapy market size has seen rapid expansion in recent years. This market is forecast to expand from $16.87 billion in 2025 to $19.31 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be attributed to the high cost associated with autologous therapies, constraints in donor availability, the absence of standardized manufacturing processes, early successes in clinical trials, and an increasing incidence of chronic diseases.

The cell therapy market is projected to experience substantial expansion in the upcoming years, with its valuation expected to reach $32.48 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 13.9%. This predicted rise over the forecast period is primarily driven by advances in gene editing techniques, increased automation in cell manufacturing, a surge in investments directed towards cell therapy startups, the rising demand for regenerative medicine solutions, and the broadening application of these therapies across oncology and cardiovascular diseases. Significant trends during this period are anticipated to include the development of personalized cell therapies, advancements in allogeneic therapies, improvements in cell storage and transportation methods, innovations in regulatory and compliance protocols, and the emergence of new clinical applications.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Primary Factors Are Fueling The Expansion Of The Cell Therapy Market?

The increasing occurrence of chronic illnesses supported the growth of the cell therapy sector. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a long-term ailment, lasting a year or longer, often needing medical care, restricting daily activities, or both, encompassing conditions such as heart disease, cancer, diabetes, and Parkinson’s disease. Stem cell applications offer advantages for individuals afflicted with spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For example, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency based in the US, issued important updates concerning public health programs. Annually, more than 944,800 Americans succumb to heart disease or stroke, making up over one-third of all fatalities. In the U.S., 1.7 million people are diagnosed with cancer each year, with over 600,000 deaths, positioning it as the second principal cause of mortality. Furthermore, over 38 million Americans suffer from diabetes, and an additional 98 million adults are prediabetic, elevating their susceptibility to type 2 diabetes. Diabetes has the potential to result in serious complications such as heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, intensifying the likelihood of chronic conditions including type 2 diabetes, heart disease, and specific cancers. The expanding occurrence of chronic illnesses boosted the need for cell therapies and supported the development of the cell therapy market.

What Are The Major Segment Categories Within The Cell Therapy Market?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Trends Are Influencing The Future Of The Cell Therapy Market?

Major companies within the cell therapy market are engaged in the development of advanced, multi-targeted treatments, leveraging robust early-stage clinical findings to boost efficacy and address unmet medical demands in challenging cancers. An illustrative example occurred in June 2025, when Johnson & Johnson, a US-based pharmaceutical entity, disclosed encouraging preliminary outcomes from its Phase 1b investigation of JNJ-4496. This specific therapy is a dual-targeting CAR T-cell therapy engineered to attach to both CD19 and CD20, intended for individuals with relapsed or refractory large B-cell lymphoma. Initial data, unveiled at the 2025 EHA Congress, demonstrated impressive response rates, achieving 75–80% complete responses at the optimized Phase 2 dosage, alongside an absence of Grade 3–4 cytokine release syndrome. The treatment exhibited promising safety characteristics, manageable neurotoxicity, and considerable activity even among patients who had undergone extensive prior treatments. These discoveries highlight the promise inherent in future dual-targeting CAR T methodologies and reaffirm Johnson & Johnson’s commitment to pioneering innovative therapies for B-cell malignancies.

Who Are The Leading Firms Participating In The Cell Therapy Market?

Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.

Access The Complete Cell Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Regional Market Leads The Cell Therapy Market?

North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Cell Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2026, By The Business Research Company

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Autologous Cell Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795